Skip to main content
Photocure ASA logo

Photocure ASA — Investor Relations & Filings

Ticker · PHO ISIN · NO0010000045 LEI · 5967007LIEEXZXG8OW35 OL Manufacturing
Filings indexed 1,333 across all filing types
Latest filing 2010-11-01 Transaction in Own Shar…
Country NO Norway
Listing OL PHO

About Photocure ASA

https://www.photocure.com/

Photocure is a specialty pharmaceutical company focused on bladder cancer. It develops and commercializes products and medical devices based on proprietary photodynamic technology. The company's primary offering is Blue Light Cystoscopy (BLC) with its imaging agents, Hexvix®/Cysview®, which is used for the improved detection and management of bladder cancer. Photocure aims to deliver transformative solutions to the urologic oncology community to improve patient outcomes. The company is also engaged in developing advanced diagnostic technologies, including the integration of artificial intelligence with its BLC systems.

Recent filings

Filing Released Lang Actions
Photocure ASA - Notification of trade
Transaction in Own Shares Classification · 100% confidence The document is a short notification regarding the company's share buyback program, specifically detailing the purchase of 1,000 shares. This falls under the category of a company buying back its own shares, which is explicitly defined as 'Transaction in Own Shares' (POS).
2010-11-01 English
Photocure ASA - Notification of trade
Transaction in Own Shares Classification · 100% confidence The document is a short notification regarding the company's purchase of its own shares as part of a share buyback program. It specifies the number of shares purchased, the average price, and the updated total of treasury shares held. This aligns perfectly with the definition for 'Transaction in Own Shares' (POS).
2010-10-29 English
Photocure ASA - Kjøp av egne aksjer
Transaction in Own Shares Classification · 100% confidence The document is a short announcement regarding the company's purchase of its own shares (share buyback) as part of a repurchase program. It specifies the number of shares purchased, the average price, and the total holdings. This aligns perfectly with the definition for 'Transaction in Own Shares' (POS).
2010-10-29 Norwegian
Presentasjon tredje kvartal.pdf (Att: 269492)
Investor Presentation Classification · 96% confidence The document is a slide deck titled “Presentation of third quarter 2010 results” with CEO/CFO presenters, containing forward‐looking disclaimers, highlights, P&L, balance sheet, cash flow, operational updates, strategic outlook, and pipeline information. It is clearly an investor presentation summarizing financial performance and corporate strategy for Q3. Therefore, it fits the Investor Presentation category (Code: IP).
2010-10-27 English
3rd Quarter Presentation.pdf (Att: 269491)
Investor Presentation Classification · 93% confidence The document is a slide-based presentation entitled “Presentation of third quarter 2010 results,” prepared by the CEO and CFO, containing financial highlights, P&L, balance sheet, cash flow tables, operational updates, and strategic outlook in a PowerPoint format. It is clearly intended as an investor deck rather than an official earnings release, regulatory report, or full interim report. Therefore it fits the definition of an Investor Presentation.
2010-10-27 English
Presentasjon resultater 3. kvartal 2010
Report Publication Announcement Classification · 95% confidence The document is a short announcement (502 characters) stating that a presentation for the 3rd quarter results is attached. It provides contact information and references a regulatory requirement for disclosure. Per the 'Menu vs Meal' rule, since this is a short announcement of a report rather than the report itself, it is classified as a Report Publication Announcement.
2010-10-27 Norwegian

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.